BIOMAT Database Logo BIOMAT Database Logo

Clinical experience with the use of R48 (NN-di-2'-chloroethyl-2'-naphthylamine). 1958

W D RIDER, and O H WARWICK

UI MeSH Term Description Entries
D008466 Mechlorethamine A biologic alkylating agent that exerts its cytotoxic effects by forming DNA ADDUCTS and DNA interstrand crosslinks, thereby inhibiting rapidly proliferating cells. The hydrochloride is an antineoplastic agent used to treat HODGKIN DISEASE and LYMPHOMA. Chlorethazine,Chlormethine,Mechlorethamine Oxide,Mustine,Nitrogen Mustard,Nitrogen Mustard N-Oxide,Bis(2-chloroethyl)methylamine,Caryolysine,Cloramin,Embichin,Mechlorethamine Hydrochloride,Mechlorethamine Hydrochloride N-Oxide,Mechlorethamine N-Oxide,Methylchlorethamine,Mitomen,Mustargen,NSC-10107,NSC-762,Nitrogranulogen,Nitromin,Hydrochloride N-Oxide, Mechlorethamine,Hydrochloride, Mechlorethamine,Mechlorethamine Hydrochloride N Oxide,Mechlorethamine N Oxide,N-Oxide, Mechlorethamine Hydrochloride,N-Oxide, Nitrogen Mustard,NSC 10107,NSC 762,NSC10107,NSC762,Nitrogen Mustard N Oxide
D009588 Nitrogen Mustard Compounds A group of alkylating agents derived from mustard gas, with the sulfur replaced by nitrogen. They were formerly used as toxicants and vesicants, but now function as antineoplastic agents. These compounds are also powerful mutagens, teratogens, immunosuppressants, and carcinogens. Compounds, Nitrogen Mustard,Mustard Compounds, Nitrogen
D000588 Amines A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amine

Related Publications

W D RIDER, and O H WARWICK
Aromatic nitrogen mustards in the reticuloses with special reference to R48 [di(2-chloroethyl)-beta-naphthylamine].
September 1951, The British journal of radiology,
W D RIDER, and O H WARWICK
Clinical experience with CB 1348 (NN-di(2-chloroethyl, -P-aminophenylbutyric acid) in the treatment of chronic lymphatic leukaemia.
March 1957, Acta radiologica,
W D RIDER, and O H WARWICK
[Clinical experience with the use of p-(N,N-di-2-chloroethyl) aminophenylbutyric acid in the chemotherapy of various hemolymphoblastoses].
February 1958, Il Progresso medico,
W D RIDER, and O H WARWICK
Cytotoxic compounds. X. Carbamates derived from NN-bis-(2-chloroethyl)-m- and NN-bis-(2-chloroethyl)-p-phenylenediamine.
January 1970, Journal of the Chemical Society. Perkin transactions 1,
W D RIDER, and O H WARWICK
Oral treatment of polycythaemia vera with beta-naphthyl-di-2-chloroethylamine (R48).
September 1951, British medical journal,
W D RIDER, and O H WARWICK
[Therapy of leukemia with chloroethyl-naphthylamine compounds].
November 1951, Gazzetta medica italiana,
W D RIDER, and O H WARWICK
Preliminary clinical trial of p-di-2-chloroethyl-amino-L-phenylalanine (CB 3025, melphalan) and of di-2-chloroethyl methanesulfonate (CB 1506).
April 1958, Annals of the New York Academy of Sciences,
W D RIDER, and O H WARWICK
[Preparation of a water-soluble derivatives of bis(2-chloroethyl)-naphthylamine].
January 1956, Il Farmaco; edizione scientifica,
W D RIDER, and O H WARWICK
[Characteristics of an aromatic nitrogen mustard; bis (2-chloroethyl)-beta naphthylamine].
January 1950, Il Farmaco, scienza e tecnica,
W D RIDER, and O H WARWICK
[Research on indications of N,N-bis (2-chloroethyl)-2-naphthylamine in anticancerous chemotherapy].
December 1954, Revue medicale de Liege,
Copied contents to your clipboard!